Glaxo pays 41 million to settle US drug quality matter

June 23, 2011

British pharmaceutical giant GlaxoSmithKline said Thursday it is paying 41 million dollars to settle allegations of poor drug quality at a manufacturing plant in Puerto Rico.

The drugmaker did not admit to any at the now shuttered factory, but said it agreed to the settlement "to avoid the expense and uncertainty of protracted litigation and trial," a company statement said.

The payment will be distributed across 37 states and the District of Columbia.

"The company did not admit to any wrongdoing or liability of any kind under these states' consumer protection laws in this settlement," the statement said. At the center of the dispute is a plant in Cidra. A company insider told the US news show 60 Minutes in January that contaminated and poorly dosed medications were being produced there. A federal investigation ensued.

rejected the accusations and said there was no evidence that patients had been harmed.

Federal regulators, the US Department of Justice and the whistelblower Cheryl Eckard's attorney, "all stated there was no indication that patients were harmed as a result of the production issues at Cidra," the company said in response to the CBS report.

GlaxoSmithKline said it closed the plant in 2009 because of "declining demand for the medicines made there."

Before selling the factory in 2010, the drugmaker insisted it "brought it into compliance and to a high level of performance that satisfied both GSK and the FDA ()."

Related Stories

Recommended for you

Opioid addiction treatment behind bars reduced post-incarceration overdose deaths in RI

February 14, 2018
A treatment program for opioid addiction launched by the Rhode Island Department of Corrections was associated with a significant drop in post-incarceration drug overdose deaths and contributed to an overall drop in overdose ...

Heroin vaccine blocks lethal overdose

February 14, 2018
Scientists at The Scripps Research Institute (TSRI) have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block lethal overdose of the drug. Their research, published ...

Study shows NIH spent >$100 billion on basic science for new medicines

February 12, 2018
Federally funded research contributed to the science underlying all new medicines approved by the FDA over the past six years, according to a new study by Bentley University.

Opioid use increases risk of serious infections

February 12, 2018
Opioid users have a significantly increased risk of infections severe enough to require treatment at the hospital, such as pneumonia and meningitis, as compared to people who don't use opioids.

Placebo pills prescribed honestly help cancer survivors manage symptoms

February 9, 2018
Long after cancer treatment ends, many continue to deal with one particular symptom that refuses to go away: fatigue. In a new study, researchers at the University of Alabama at Birmingham and Harvard Medical School have ...

Multinational companies continue to produce unregulated antibiotics in India

February 5, 2018
Millions of unapproved antibiotics are being sold in India, according to a new study by researchers at Queen Mary University of London and Newcastle University.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.